ResearcherChulalongkorn UniversityActive in the last 2 years
Pinit Kullavanijaya
Matched on OpenAlex author ID A5010758713. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 3
- One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequency ablation. Co-author DOI 10.1016/j.gie.2025.06.008↗
- EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observational open-label pilot study. Co-author DOI 10.1097/eus.0000000000000003↗
- Pancreatic cancer in an Asian population. Last author DOI 10.4103/2303-9027.151361↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pradermchai Kongkam · 3 shared papers, 2015–2025 · strength 0.42
- Paper One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequenc… DOI 10.1016/j.gie.2025.06.008↗
- Paper EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observa… DOI 10.1097/eus.0000000000000003↗
- Paper Pancreatic cancer in an Asian population. DOI 10.4103/2303-9027.151361↗
- Rungsun Rerknimitr · 3 shared papers, 2015–2025 · strength 0.42
- Paper One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequenc… DOI 10.1016/j.gie.2025.06.008↗
- Paper EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observa… DOI 10.1097/eus.0000000000000003↗
- Paper Pancreatic cancer in an Asian population. DOI 10.4103/2303-9027.151361↗
- Phonthep Angsuwatcharakon · 2 shared papers, 2023–2025 · strength 0.37
- Paper One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequenc… DOI 10.1016/j.gie.2025.06.008↗
- Paper EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observa… DOI 10.1097/eus.0000000000000003↗
- Kasenee Tiankanon · 2 shared papers, 2023–2025 · strength 0.37
- Paper One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequenc… DOI 10.1016/j.gie.2025.06.008↗
- Paper EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observa… DOI 10.1097/eus.0000000000000003↗
- Thanawat Luangsukrerk · 2 shared papers, 2023–2025 · strength 0.37
- Paper One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequenc… DOI 10.1016/j.gie.2025.06.008↗
- Paper EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observa… DOI 10.1097/eus.0000000000000003↗
- Parit Mekaroonkamol · 1 shared paper, 2025 · strength 0.21
- Dong Wan Seo · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.